Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity

标题
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
作者
关键词
Multiple Sclerosis, Experimental Autoimmune Encephalomyelitis, Glatiramer Acetate, Statin Treatment, Teriflunomide
出版物
Journal of Neuroinflammation
Volume 11, Issue 1, Pages 29
出版商
Springer Nature
发表日期
2014-02-06
DOI
10.1186/1742-2094-11-29

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started